Cargando…

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Increased risk of colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients has been attributed to long-standing chronic inflammation, with the contribution of genetic alterations and environmental factors such as the microbiota. Moreover, accumulating data indicate that IBD-associated CR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucafò, Marianna, Curci, Debora, Franzin, Martina, Decorti, Giuliana, Stocco, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563785/ https://www.ncbi.nlm.nih.gov/pubmed/34744751 http://dx.doi.org/10.3389/fphar.2021.772101

Ejemplares similares

Microbiota and Drug Response in Inflammatory Bowel Disease
por: Franzin, Martina, et al.
Publicado: (2021)

Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
por: Curci, Debora, et al.
Publicado: (2022)

Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease
por: Curci, Debora, et al.
Publicado: (2021)

A Validated HPLC–Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside
por: Franzin, Martina, et al.
Publicado: (2022)

Patient-derived organoids for therapy personalization in inflammatory bowel diseases
por: Lucafò, Marianna, et al.
Publicado: (2022)

Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease
por: Lucafò, Marianna, et al.
Publicado: (2021)

Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients
por: Lucafò, Marianna, et al.
Publicado: (2019)

Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease
por: Di Silvestre, Alessia, et al.
Publicado: (2019)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells
por: Zudeh, Giulia, et al.
Publicado: (2023)

Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants
por: Lucafò, Marianna, et al.
Publicado: (2019)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
por: Genova, Elena, et al.
Publicado: (2019)

High-Throughput Sequencing of microRNAs in Glucocorticoid Sensitive Paediatric Inflammatory Bowel Disease Patients
por: De Iudicibus, Sara, et al.
Publicado: (2018)

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway
por: Lucafò, Marianna, et al.
Publicado: (2020)

Long Non-Coding RNA GAS5 and Intestinal MMP2 and MMP9 Expression: A Translational Study in Pediatric Patients with IBD
por: Lucafò, Marianna, et al.
Publicado: (2019)

A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis
por: Franzin, Martina, et al.
Publicado: (2022)

Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report
por: Burlo, Francesca, et al.
Publicado: (2023)

Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy
por: Franzin, Martina, et al.
Publicado: (2023)

A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
por: Montecchini, Oksana, et al.
Publicado: (2021)

Genetic determinants for methotrexate response in juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2015)

Induced pluripotent stem cells as an innovative model to study drug induced pancreatitis
por: Genova, Elena, et al.
Publicado: (2021)

Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease
por: Zheng, Yang, et al.
Publicado: (2021)

Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
por: Basso, Paulo José, et al.
Publicado: (2019)

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2019)

Biophysics, pathophysiology, and pharmacology of ion channel gating pores
por: Moreau, Adrien, et al.
Publicado: (2014)

Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
por: Pagnini, Cristiano, et al.
Publicado: (2019)

Biomarkers for gastrointestinal adverse events related to thiopurine therapy
por: Zudeh, Giulia, et al.
Publicado: (2021)

Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology
por: Xiao, Qing-Ao, et al.
Publicado: (2022)

Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease
por: Mohajeri, Sahar, et al.
Publicado: (2022)

The mechanism of vitamin D3 in preventing colorectal cancer through network pharmacology
por: Rong, Kang, et al.
Publicado: (2023)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Zhou, Mengjiao, et al.
Publicado: (2022)

Tibetan Medicine for Diabetes Mellitus: Overview of Pharmacological Perspectives
por: Yan, Li-Shan, et al.
Publicado: (2021)

Inflammatory pathophysiological mechanisms implicated in postpartum depression
por: Zhu, Jialei, et al.
Publicado: (2022)

A Pharmacological Overview of Alpinumisoflavone, a Natural Prenylated Isoflavonoid
por: Ateba, Sylvin Benjamin, et al.
Publicado: (2019)

Novel potential pharmacological applications of dimethyl fumarate—an overview and update
por: Bresciani, Giorgia, et al.
Publicado: (2023)

Rhein for treating diabetes mellitus: A pharmacological and mechanistic overview
por: Deng, Tingting, et al.
Publicado: (2023)

An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome
por: Jun, Hyejin, et al.
Publicado: (2022)

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2k0va62gu3am804nbtm7lv6729